The effect of age on the response to the pneumococcal polysaccharide vaccine
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The effect of age on the response to the pneumococcal polysaccharide vaccine ; volume:10 ; number:1 ; day:10 ; month:3 ; year:2010 ; pages:1-8 ; date:12.2010
BMC infectious diseases ; 10, Heft 1 (10.3.2010), 1-8, 12.2010
- Urheber
-
Lee, Hyunju
- Beteiligte Personen und Organisationen
-
Nahm, Moon H.
Kim, Kyung-Hyo
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-10-60
- URN
-
urn:nbn:de:1111-2016030257811
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Hyunju
- Nahm, Moon H.
- Kim, Kyung-Hyo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Maternal vaccination for the protection of the newborn with pneumococcal polysaccharide vaccine in Gambia, West Africa
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease among 948,263 individuals ≥ 65 years of age: a Danish cohort study
A case series evaluating the serological response of adult asthma patients to the 23-valent pneumococcal polysaccharide vaccine
Effectiveness of the polysaccharide pneumococcal vaccine among HIV-infected persons in Brazil: a case control study
Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review
Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Maternal vaccination for the protection of the newborn with pneumococcal polysaccharide vaccine in Gambia, West Africa
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease among 948,263 individuals ≥ 65 years of age: a Danish cohort study
A case series evaluating the serological response of adult asthma patients to the 23-valent pneumococcal polysaccharide vaccine
Effectiveness of the polysaccharide pneumococcal vaccine among HIV-infected persons in Brazil: a case control study
Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review
Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Maternal vaccination for the protection of the newborn with pneumococcal polysaccharide vaccine in Gambia, West Africa
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease among 948,263 individuals ≥ 65 years of age: a Danish cohort study
A case series evaluating the serological response of adult asthma patients to the 23-valent pneumococcal polysaccharide vaccine
Effectiveness of the polysaccharide pneumococcal vaccine among HIV-infected persons in Brazil: a case control study
Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review
Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review